Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170038/S034

CentriMag Circulatory Support System

Abbott · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONP170038/S034

What did the FDA decide?

FDA posted a 30-day notice for supplement S034 to PMA P170038 for the CentriMag Circulatory Support System. The stated decision scope is a manufacturing process change to the routine bioburden monitoring program for the CentriMag Blood Pump. The supplement type is listed as Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the decision is recorded as OK30.

This notice does not represent a new approval of the entire system or a change in indication. The source statement identifies only the bioburden monitoring program change; it does not describe the specific monitoring method, acceptance criteria, or manufacturing site affected. No safety or effectiveness conclusion is provided in the source fields.

FDA approval order statement

a manufacturing process change to the routine bioburden monitoring program for the CentriMag Blood Pump
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 30, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P170038/S034
Regulatory pathway
PMA supplement
Applicant
Abbott
Product code
DSQ
Decision code
OK30
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Applicant
Abbott
Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P170038. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P170038 · Original PMA

    CentriMag Circulatory Support System

  2. P170038/S032 · Related supplement

    CentriMag Circulatory Support System

  3. P170038/S034 received

    Application receipt date recorded by FDA.

  4. P170038/S033 · Related supplement

    CentriMag Circulatory Support System

  5. P170038/S034 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P170038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170038

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA approvalDec 6, 2019FDA
AbbottPMA supplementSep 2, 2026FDA
AbbottPMA supplementOct 2, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6035 Stoneridge Dr., Pleasanton, CA, 94588

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records